Epstein-Barr virus antibody level and gastric cancer risk in Korea: A nested case-control study

British Journal of Cancer

Volumn 101, Issue 3, 2009, Pages 526-529

  Kim, Y ^a   Shin, A ^a   Gwack, J ^b   Ko, K P ^c   Kim, C S ^c   Park, S K ^b   Hong, Y C ^b   Kang, D ^b   Yoo, K Y ^b  

^a National Cancer Center   (South Korea)

^b Seoul National University   (South Korea)

^c Korea Centers for Disease Control and Prevention   (South Korea)

Author keywords

Epstein?Barr virus; Korea; Nested case?control study; Stomach neoplasms

Indexed keywords

EARLY ANTIGEN; EPSTEIN BARR VIRUS ANTIBODY; EPSTEIN BARR VIRUS ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS CAPSID ANTIGEN;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CANCER;

ADULT; AGED; ANTIBODIES, VIRAL; CAPSID PROTEINS; CASE-CONTROL STUDIES; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 68149157507     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605146     Document Type: Article

References (21)

1. Akiba S, Koriyama C, Herrera-Goepfert R, Eizuru Y (2008) Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features. Cancer Sci 99: 195-201
2. Akre O, Lipworth L, Tretli S, Linde A, Engstrand L, Adami HO, Melbye M, Andersen A, Ekbom A (1999) Epstein-Barr virus and cytomegalovirus in relation to testicular-cancer risk: a nested case-control study. Int J Cancer 82: 1-5
3. Bruu AL, Hjetland R, Holter E, Mortensen L, Natas O, Petterson W, Skar AG, Skarpaas T, Tjade T, Asjo B (2000) Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Clin Diagn Lab Immunol 7: 451-456
4. Burgess DE, Woodman CB, Flavell KJ, Rowlands DC, Crocker J, Scott K, Biddulph JP, Young LS, Murray PG (2002) Low prevalence of Epstein-Barr virus in incident gastric adenocarcinomas from the United Kingdom. Br J Cancer 86: 702-704
5. Chang MS, Kim WH (2005) Epstein-Barr virus in human malignancy: a special reference to Epstein-Barr virus associated gastric carcinoma. Cancer Res Treat 37: 257-267
6. Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ, Yang CS (2001) Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 345: 1877-1882
7. Correa P, Piazuelo MB, Camargo MC (2004) The future of gastric cancer prevention. Gastric Cancer 7: 9-16
8. Gartner BC, Hess RD, Bandt D, Kruse A, Rethwilm A, Roemer K, Mueller-Lantzsch N (2003) Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method. Clin Diagn Lab Immunol 10: 78-82
9. Geser A, de The G, Lenoir G, Day NE, Williams EH (1982) Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt's lymphoma. Int J Cancer 29: 397-400
10. Gwack J, Shin A, Kim CS, Ko KP, Kim Y, Jun JK, Bae J, Park SK, Hong YC, Kang D, Chang SH, Shin HR, Yoo KY (2006) CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case-control study in Korea. Br J Cancer 95: 639-641
11. Herrera-Goepfert R, Akiba S, Koriyama C, Ding S, Reyes E, Itoh T, Minakami Y, Eizuru Y (2005) Epstein-Barr virus-associated gastric carcinoma: evidence of age-dependence among a Mexican population. World J Gastroenterol 11: 6096-6103
12. IARC (1997) Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon: IARC Press
13. Koshiol J, Qiao YL, Mark SD, Dawsey SM, Abnet CC, Kamangar F, Lennette ET, Dong ZW, Taylor PR (2007) Epstein-Barr virus serology and gastric cancer incidence and survival. Br J Cancer 97: 1567-1569
14. Lehtinen T, Lumio J, Dillner J, Hakama M, Knekt P, Lehtinen M, Teppo L, Leinikki P (1993) Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies - a prospective study. Cancer Causes Control 4: 187-193
15. Levine PH, Stemmermann G, Lennette ET, Hildesheim A, Shibata D, Nomura A (1995) Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma. Int J Cancer 60: 642-644
16. Macsween KF, Crawford DH (2003) Epstein-Barr virus-recent advances. Lancet Infect Dis 3: 131-140
17. Ouburg S, Bart ACJ, Klinkenberg-Knol EC, Mulder CJ, Salvador Pena A, Morre SA (2005) A candidate gene approach of immune mediators effecting the susceptibility to and severity of upper gastrointestinal tract diseases in relation to Helicobacter pylori and Epstein-Barr virus infections. Eur J Gastroenterol Hepatol 17: 1213-1224
18. Shinkura R, Yamamoto N, Koriyama C, Shinmura Y, Eizuru Y, Tokunaga M (2000) Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan. J Med Virol 60: 411-416
19. Tedeschi R, Bloigu A, Ogmundsdottir HM, Marus A, Dillner J, dePaoli P, Gudnadottir M, Koskela P, Pukkala E, Lehtinen T, Lehtinen M (2007) Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring. Am J Epidemiol 165: 134-137
20. Tokunaga M, Land CE (1998) Epstein-Barr virus involvement in gastric cancer: biomarker for lymph node metastasis. Cancer Epidemiol Biomarkers Prev 7: 449-450
21. Yoo KY, Shin HR, Chang SH, Lee KS, Park SK, Kang D, Lee DH (2002) Korean Multi-center Cancer Cohort Study including a Biological Materials Bank (KMCC-I). Asian Pac J Cancer Prev 3: 85-92